OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)

NARecruitingINTERVENTIONAL
Enrollment

208

Participants

Timeline

Start Date

February 14, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

May 31, 2026

Conditions
HypertensionSelf-ManagementTechnologyQuality of Life
Interventions
BEHAVIORAL

OPTIMA-BP Intervention

"Participants will continue their regular medical care, supplemented by the OPTIMA-BP intervention:~1. Six weekly web-based education sessions on hypertension management.~2. Access to Medisafe, a medication management application (app) with a personalized medication adherence support (SMS reminder messages, adherence feedback, etc.) for 6 months.~3. Home Blood Pressure Monitoring (Omron series 10 home BP monitor). Participants will be asked to monitor and record their BP, 2x daily (AM and PM), twice a week, in a tracking log for 6 months.~4. Nurse Counseling Session with a research nurse for informal counseling, social support, and follow-up sessions regarding progress.~5. Optimizing HTN Treatment with 208 AA participants, in conjunction with their physician to maintain treatment goal BP: \< 130/80 mmHg. based on current HTN guidelines and study recommendations including chlorthalidone 12.5-25 mg/day or amlodipine 5-10 mg/day or as chosen by their doctor."

Trial Locations (1)

44143

RECRUITING

Case Western Reserve University, Cleveland

All Listed Sponsors
collaborator

University Hospitals Cleveland Medical Center

OTHER

lead

Case Western Reserve University

OTHER